Literature DB >> 14257741

RETROPERITONEAL FIBROSIS IN PATIENTS TAKING METHYSERGIDE.

D C UTZ, E D ROOKE, J A SPITTELL, L G BARTHOLOMEW.   

Abstract

Entities:  

Keywords:  DRUG THERAPY; DUODENAL ULCER; HYDRONEPHROSIS; METHYSERGIDE; MIGRAINE; PERITONEAL DISEASES; PREDNISONE, THERAPEUTIC; RETROPERITONEAL FIBROSIS; TOXICOLOGIC REPORT; URETERAL OBSTRUCTION; UROGRAPHY

Mesh：

Substances：

Year:  1965        PMID： 14257741     DOI： 10.1001/jama.1965.03080120017005

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  17 in total

1.  Drug-induced retroperitoneal fibrosis: short aetiopathogenetic note, from the past times of ergot-derivatives large use to currently applied bio-pharmacology.

Authors:  C Alberti
Journal:  G Chir       Date:  2015 Jul-Aug

Review 2.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

3.  More retroperitoneal fibrosis.

Authors: 
Journal:  Br Med J       Date:  1967-10-07

4.  Retroperitoneal fibrosis secondary to methysergide bimaleate.

Authors:  N C Kerbel
Journal:  Can Med Assoc J       Date:  1967-05-27       Impact factor: 8.262

5.  [Idiopathic mediastinal fibrosis].

Authors:  G Elias; P Grondin; I Dyrda
Journal:  Can Med Assoc J       Date:  1971-10-09       Impact factor: 8.262

6.  Combined mediastinal and retroperitoneal fibrosis.

Authors:  H W Salmon
Journal:  Thorax       Date:  1968-03       Impact factor: 9.139

7.  Retroperitoneal fibrosis.

Authors:  J C Ross
Journal:  Proc R Soc Med       Date:  1968-02

8.  Idiopathic retroperitoneal fibrosis.

Authors:  L R Pathak; R C Renjhen; C P Chandra
Journal:  Postgrad Med J       Date:  1971-10       Impact factor: 2.401

9.  Surgical treatment of retroperitoneal fibrosis.

Authors:  C B Hewitt; G L Nitz; W S Kiser; R A Straffon; B H Stewart
Journal:  Ann Surg       Date:  1969-04       Impact factor: 12.969

Review 10.  Orbital involvement in multifocal fibrosclerosis.

Authors:  G W Aylward; T J Sullivan; A Garner; I Moseley; J E Wright
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.